A Study to Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients
Clinical trial NCT05153915 · COMPLETED
Trial details
- NCT number
- NCT05153915
- Sponsor
- Astellas Pharma China, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-30
- Primary completion
- 2024-03-14
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.